Webinar Announcement | Chromatography Data System for regulated Laboratories | Part 2 – Get the most out of CDS
Posts
Build a more Secure, Connected and Regulated Bioequivalence Lab
Electronic records obtained from LCMSMS analysis Data Systems are required to be securely archived (Data Management System), maintained throughout the lifecycle of the data, and backed up (Scientific Data Management System). Data for BE studies are often transferred electronically between organizations involved in the studies, verification that the software used by each organization is compatible with the others and that there is no impact on the data so-transferred, should be conducted before commencing key study-related tasks. Join us to learn deeper into this subject. Webinar Announcement: Build a more secure, connected and regulated Bioequivalence Lab
LabCast Session: Effective ways of managing scientific data in analytical labs
Effective data management is a crucial piece of deploying the IT systems that run lab applications and provide analytical information to help drive scientific and operational decision-making and strategic planning by executives, managers, and end-users. Register for this webinar https://www.linkedin.com/posts/kameshwaran_labcast-session-effective-ways-of-managing-activity-6676769940088856576-e9Vh
An Ecosystem for a Digital Lab - Aspects and Possibilities
What is the future lab going to be, what are the visions for a smart lab a digital lab? https://lnkd.in/g2jfB6C hashtag # laboratory hashtag # smartlab hashtag # digitallab hashtag # labautomation hashtag # labworkflow hashtag # lab
Data Integrity for Non-Chromatography analytical instruments and Risk mitigation for standalone workstation data
Join us for a live LabCast on 15 April 3 pm onwards to discuss on Data Integrity for Non-Chromatography analytical instruments and Risk mitigation for standalone workstation data. https://www.linkedin.com/posts/kameshwaran_managing-compliance-data-integrity-for-activity-6654326452684713984-GjKi
Autocalculations and learn about eliminating excel based components!
Autocalculations and learn about eliminating excel based components! Would you like to know more? Join this Agilent LabCast on Autocalculations and learn about eliminating excel based components, while enhancing productivity and reducing human-errors. https://www.linkedin.com/posts/kameshwaran_welcome-you-are-invited-to-join-a-meeting-activity-6652880875912511488-VZkA
LabCast Session: Get the Most Out of Your Chromatography Data System
Live Labcast: Enhance productivity with ease of use. Get the Most Out of Your Chromatography Data System with Agilent OpenLab CDSJoin us for live labcast on 30th March, 2020 from 3-4pm https://www.linkedin.com/posts/kameshwaran_labcast-session-get-the-most-out-of-your-activity-6648872465445552128-59f-
Data Integrity is your issue? How can I get tips on handling compliance queries during audits?
Data Integrity is your issue? How can I get tips on handling compliance queries during audits? Why data review process is so important ? Need answers to these questions? Join us for a live Labcast on Enhanced compliance, data integrity and tips on how to face audits on 23rd March from 3PM to 4PM IST https://lnkd.in/ffFZPTj https://www.linkedin.com/posts/kameshwaran_openlab-cds-enhanced-compliance-data-integrity-activity-6646664205363712000-a_LL
Thermo Fisher Scientific to Acquire QIAGEN N.V.
• Expands specialty diagnostics portfolio with attractive molecular diagnostics capabilities, including infectious disease testing • Complements leading life sciences offering with innovative sample preparation, assay and bioinformatics technologies • Creates significant value and is expected to be immediately accretive to adjusted earnings per share after close WALTHAM, Mass. and VENLO, The Netherlands – March 3, 2020 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of molecular diagnostics and sample preparation technologies, today announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher’s proposal to acquire QIAGEN for €39 per share in cash. The offer price represents a premium of approximately 23% to the closing price of QIAGEN’s common stock on the Frankfurt Prime Standard on March